Most Recent
A Globaltech patent for mining survey tools is facing another test, with rival technology company Reflex Technologies lodging an appeal after its invalidity challenge flopped.
Samsung Bioepis Australia has sued fellow biotechnology company Fresenius Kabi over a biosimilar of top selling immunosuppressant drug Humira, saying the invention ‘does not achieve the promise’ of a better formulation using fewer ingredients.
Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for an early launch of a generic version of blockbuster cancer drug Revlimid.
Kmart Australia has resolved a case brought by UK-based Jellycat that accused the retailer of selling knockoffs of the plush toy designer's signature 'Bashful Bunny'.
IP Australia has rejected the patent application of Scandinavian dairy giant Arla Foods amba, finding its high-protein whey-based yoghurt invention lacked an inventive step.
Trading firm Epoch Capital has brought proceedings against a quantitative analyst who allegedly downloaded confidential information from the firm’s computers.
T-shirts and face masks sold on Redbubble violate Hells Angels' trademarks, a judge has found, banning the online marketplace from further sales of infringing products and awarding damages to the motorcycle group.
The Productivity Commission has called for new laws that would allow traditional owners to take legal action when their cultural property is used without permission in the $250 million Aboriginal arts and crafts industry.
German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.
Technology company Reflex Instruments has lost its challenge to rival Globaltech’s patent for two mining survey tools, with a judge finding Reflex had not established the technology wasn't novel and lacked an inventive step.